| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1221793-31-2 | N-Cyclohexylpropyl Deoxynojirimycin, Hydrochloride | C15H30ClNO4 |
| 1221793-34-5 | (3S,4aS,8aS)-2-[(2R,3R)-3-Amino-2-hydroxy-4-phenylthiobutyl]-decahydro-3-isoquinolinecarboxylic Acid | C20H30N2O3S |
| 1221793-42-5 | (2S)-4,4-Difluoro-1,2-piperidinedicarboxylic acid 1-(1,1-dimethylethyl) ester | C11H17F2NO4 |
| 1221793-58-3 | N-BOC 4-iodo-3-Methylaniline | |
| 1221793-59-4 | 4,6-Difluorobenzo[c][1,2,5]thiadiazole | |
| 1221793-60-7 | 3-BroMo-5-fluoropyridine 1-oxide | |
| 1221793-61-8 | 1-BroMo-3-isopropoxy-5-trifluoroMethoxybenzene | |
| 1221793-62-9 | 3-BroMo-5-chloropyridine 1-oxide | |
| 1221793-63-0 | 2-Ethoxy-8-Methylquinoline | |
| 1221793-64-1 | 1-BroMo-3-isobutoxy-5-trifluoroMethoxybenzene | |
| 1221793-65-2 | 1-BroMo-3-propoxy-5-trifluoroMethoxybenzene | |
| 1221793-66-3 | 4,6-Difluoro-1H-benzo[d]iMidazol-2(3H)-one | |
| 1221793-67-4 | 5-Chloro-3-ethoxy-2-Methoxypyridine | |
| 1221793-68-5 | 3-Chloro-5-fluoropyridine 1-oxide | |
| 1221793-69-6 | 2-(5-BroMo-2-Methoxyphenoxy)acetonitrile | |
| 1221793-70-9 | 2-(2,6-DibroMo-4-nitrophenoxy)acetonitrile | |
| 1221794-83-7 | (Z)-Methyl 2-cyano-2-(5-nitropyridin-2(1H)-ylidene)acetate | |
| 1221795-90-9 | 2-Acetamido-4,6-O-benzylidene-N-(tert-butoxycarbonyl)-1,2,5-trideoxy-1,5-imino-D-glucitol | C20H28N2O6 |
| 1221795-92-1 | 2-Acetamido-3-O-acetyl-4,6-O-benzylidene-N-(tert-butoxycarbonyl)-1,2,5-trideoxy-1,5-imino-D-glucitol | C22H30N2O7 |
| 1221819-51-7 | 3-(4-Chlorophenyl)-3-oxetaneacetic acid ethyl ester | C13H15ClO3 |
| 1221885-61-5 | 6,7-Di(trideuteromethoxy)-3,4-dihydroisoquinoline | C11H7D6NO2 |
| 1221892-23-4 | Dacomitinib Impurity 2F3LAJ | C15H12ClFN4O |
| 1221901-53-6 | (11bR)-N-Benzyl-N-phenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine | C33H24NO2P |
| 1221971-47-6 | N-(3',4'-Dichloro[1,1'-biphenyl]-4-yl)-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | C21H14Cl2N2O4S |
| 1222007-94-4 | 9,9'-Spirobi[9H-fluorene]-2,2'-diylbis[boronic acid] | C25H18B2O4 |
| 1222008-13-0 | B,B'-2,8-Dibenzofurandiylbisboronic acid | C12H10B2O5 |
| 1222097-72-4 | S38093 HCl | C17H25ClN2O2 |
| 1222174-92-6 | 5-Bromo-1-methyl-1H-pyrazole-3-carboxylic acid methyl ester | C6H7BrN2O2 |
| 1222175-21-4 | 5-Bromo-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid ethyl ester | C10H9BrN2O2 |
| 1222475-77-5 | 3-Epimeliasenin B | C30H44O4 |
| 1222490-34-7 | SGD 1882 | C42H39N5O7 |
| 1222710-49-7 | (3S)-1-(Phenylmethyl)-3-piperidinecarboxylic acid | C13H17NO2 |
| 1222780-33-7 | N-[1-(1-Oxopropyl)-4-piperidinyl]-N'-[4-(trifluoromethoxy)phenyl]urea | C16H20F3N3O3 |
| 1222781-70-5 | N-[(4-Methoxyphenyl)methyl]-1-naphthalenemethanamine hydrochloride (1:1) | C19H19NO.HCl |
| 1222800-79-4 | ML 324 | C21H23N3O2 |
| 1222950-80-2 | Osteoblast activating peptide (Sprague-Dawley rat) | C120H196N38O37 |
| 1222998-36-8 | Torin 1 | C35H28F3N5O2 |
| 1223001-51-1 | Torin 2 | C24H15F3N4O |
| 1223001-53-3 | STK16-IN-1 | C17H12FN3O |
| 1223002-54-7 | QL-IX-55 | C24H14F4N4O |
| 1223020-29-8 | 2,6-Bis[(2R,4S,5S)-1-benzyl-4,5-diphenyliMidazolidin-2-yl]pyridine | |
| 1223097-20-8 | 6"-O-acetylisovitexin | C23H22O11 |
| 1223105-51-8 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,6-difluoro-alpha-methyl-L-phenylalanine | C25H21F2NO4 |
| 1223158-00-6 | trans-Benzyl 3-aminocyclohexylcarbamate | C14H20N2O2 |
| 1223357-57-0 | Cyanine5 alkyne | C35H42ClN3O |
| 1223397-11-2 | 3-Hydroxybenzoic acid 1,1'-(3-fluoro-1,2-phenylene) ester | C20H13FO6 |
| 1223403-58-4 | Larotrectinib | C21H22F2N6O2 |
| 1223404-88-3 | 5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-amine | C16H15F2N5 |
| 1223404-89-4 | (R)-5-[2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidine | C16H14F2N4 |
| 1223404-90-7 | 5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]-3-nitropyrazolo[1,5-a]pyrimidine | C16H13F2N5O2 |